Does Nirsevimab reduce severe RSV infections and hospitalizations in pediatric infants?
Nirsevimab is a critical advancement in preventing severe RSV infections and hospitalizations in vulnerable infants.
: These results underscore Nirsevimab's vital role in preventing severe RSV infections and hospitalizations, especially among the most vulnerable infants, positioning it as a critical advancement in pediatric respiratory care.
Jimeno et al. (Fri,) studied this question.